Yuk L. Choi, Ph.D. - Publications

2011 The Chinese University of Hong Kong, Hong Kong, Hong Kong 
1. Drug resistant of pathogenic bacteria. 2. Molecular virology of HIV and HBV.

25 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Kwon MJ, Han J, Seo JH, Song K, Jeong HM, Choi JS, Kim YJ, Lee SH, Choi YL, Shin YK. CD24 Overexpression Is Associated with Poor Prognosis in Luminal A and Triple-Negative Breast Cancer. Plos One. 10: e0139112. PMID 26444008 DOI: 10.1371/journal.pone.0139112  0.36
2015 Cha JY, Wee J, Jung J, Jang Y, Lee B, Hong GS, Chang BC, Choi YL, Shin YK, Min HY, Lee HY, Na TY, Lee MO, Oh U. Anoctamin 1 (TMEM16A) is essential for testosterone-induced prostate hyperplasia. Proceedings of the National Academy of Sciences of the United States of America. PMID 26153424 DOI: 10.1073/pnas.1423827112  0.36
2015 Choi IH, Kim DW, Ha SY, Choi YL, Lee HJ, Han J. Analysis of Histologic Features Suspecting Anaplastic Lymphoma Kinase (ALK)-Positive Pulmonary Adenocarcinoma. Journal of Pathology and Translational Medicine. PMID 26095438 DOI: 10.4132/jptm.2015.05.13  0.36
2015 Lee J, Hong EC, Jeong H, Hwang JW, Kim H, Bae EK, Ahn JK, Choi YL, Han J, Cha HS, Koh EM. A novel histone deacetylase 6-selective inhibitor suppresses synovial inflammation and joint destruction in a collagen antibody-induced arthritis mouse model. International Journal of Rheumatic Diseases. 18: 514-23. PMID 25530272 DOI: 10.1111/1756-185X.12501  0.36
2015 Cha YK, Lee HY, Ahn MJ, Choi YL, Lee JH, Park K, Lee KS. Survival outcome assessed according to tumor burden and progression patterns in patients with epidermal growth factor receptor mutant lung adenocarcinoma undergoing epidermal growth factor receptor tyrosine kinase inhibitor therapy. Clinical Lung Cancer. 16: 228-36. PMID 25499173 DOI: 10.1016/j.cllc.2014.11.002  0.36
2015 Song DH, Lee B, Shin Y, Choi IH, Ha SY, Lee JJ, Hong ME, Choi YL, Han J, Um SW. Cytomorphological identification of advanced pulmonary adenocarcinoma harboring KRAS mutation in lymph node fine-needle aspiration specimens: Comparative investigation of adenocarcinoma with KRAS and EGFR mutations. Diagnostic Cytopathology. 43: 539-44. PMID 25427298 DOI: 10.1002/dc.23242  0.36
2015 Sun JM, Choi YL, Ji JH, Ahn JS, Kim KM, Han J, Ahn MJ, Park K. Small-cell lung cancer detection in never-smokers: clinical characteristics and multigene mutation profiling using targeted next-generation sequencing. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 26: 161-6. PMID 25355724 DOI: 10.1093/annonc/mdu504  0.36
2015 Jeong CJ, Lee HY, Han J, Jeong JY, Lee KS, Choi YL, Choi JY. Role of imaging biomarkers in predicting anaplastic lymphoma kinase-positive lung adenocarcinoma. Clinical Nuclear Medicine. 40: e34-9. PMID 25243942 DOI: 10.1097/RLU.0000000000000581  0.36
2015 Lee SE, Lee B, Hong M, Song JY, Jung K, Lira ME, Mao M, Han J, Kim J, Choi YL. Comprehensive analysis of RET and ROS1 rearrangement in lung adenocarcinoma. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 28: 468-79. PMID 25234288 DOI: 10.1038/modpathol.2014.107  0.36
2014 Yoon HJ, Lee HY, Han J, Choi YL. Synchronous triple primary lung cancers: a case report. Korean Journal of Radiology. 15: 646-50. PMID 25246827 DOI: 10.3348/kjr.2014.15.5.646  0.36
2014 Song DH, Choi IH, Ha SY, Han KM, Lee JJ, Hong ME, Choi YL, Jang KT, Song SY, Yi CA, Han J. Extrapulmonary lymphangioleiomyoma: clinicopathological analysis of 4 cases. Korean Journal of Pathology. 48: 188-92. PMID 25013416 DOI: 10.4132/KoreanJPathol.2014.48.3.188  0.36
2014 Lee B, Lee B, Han G, Kwon MJ, Han J, Choi YL. KRAS Mutation Detection in Non-small Cell Lung Cancer Using a Peptide Nucleic Acid-Mediated Polymerase Chain Reaction Clamping Method and Comparative Validation with Next-Generation Sequencing. Korean Journal of Pathology. 48: 100-7. PMID 24868222 DOI: 10.4132/KoreanJPathol.2014.48.2.100  0.36
2014 Choi YL, Lira ME, Hong M, Kim RN, Choi SJ, Song JY, Pandy K, Mann DL, Stahl JA, Peckham HE, Zheng Z, Han J, Mao M, Kim J. A novel fusion of TPR and ALK in lung adenocarcinoma. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 9: 563-6. PMID 24736082 DOI: 10.1097/JTO.0000000000000093  0.36
2014 Chong Y, Kim JH, Lee HY, Ahn YC, Lee KS, Ahn MJ, Kim J, Shim YM, Han J, Choi YL. Quantitative CT variables enabling response prediction in neoadjuvant therapy with EGFR-TKIs: are they different from those in neoadjuvant concurrent chemoradiotherapy? Plos One. 9: e88598. PMID 24586348 DOI: 10.1371/journal.pone.0088598  0.36
2014 Lee HY, Choi YL, Lee KS, Han J, Zo JI, Shim YM, Moon JW. Pure ground-glass opacity neoplastic lung nodules: histopathology, imaging, and management. Ajr. American Journal of Roentgenology. 202: W224-33. PMID 24555618 DOI: 10.2214/AJR.13.11819  0.36
2014 Hong M, Kim RN, Song JY, Choi SJ, Oh E, Lira ME, Mao M, Takeuchi K, Han J, Kim J, Choi YL. HIP1-ALK, a novel fusion protein identified in lung adenocarcinoma. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 9: 419-22. PMID 24518094 DOI: 10.1097/JTO.0000000000000061  0.36
2014 Kim HK, Lee HY, Choi YL, Choi SJ, Choi H, Lee J, Han J, Ahn MJ, Lee KS, Kim J. Assessment of intratumoral heterogeneity of oncogenic driver mutations in surgically-resected lung adenocarcinoma: implications of percutaneous biopsy-based molecular assay for target-directed therapy. Anticancer Research. 34: 707-14. PMID 24511003  0.36
2014 Ha SY, Choi IH, Han J, Choi YL, Cho JH, Lee KJ, Sun JM. Pleural epithelioid hemangioendothelioma harboring CAMTA1 rearrangement. Lung Cancer (Amsterdam, Netherlands). 83: 411-5. PMID 24461304 DOI: 10.1016/j.lungcan.2013.12.015  0.36
2014 Lira ME, Choi YL, Lim SM, Deng S, Huang D, Ozeck M, Han J, Jeong JY, Shim HS, Cho BC, Kim J, Ahn MJ, Mao M. A single-tube multiplexed assay for detecting ALK, ROS1, and RET fusions in lung cancer. The Journal of Molecular Diagnostics : Jmd. 16: 229-43. PMID 24418728 DOI: 10.1016/j.jmoldx.2013.11.007  0.36
2014 Sun JM, Lira M, Pandya K, Choi YL, Ahn JS, Mao M, Han J, Park K, Ahn MJ, Kim J. Clinical characteristics associated with ALK rearrangements in never-smokers with pulmonary adenocarcinoma. Lung Cancer (Amsterdam, Netherlands). 83: 259-64. PMID 24300132 DOI: 10.1016/j.lungcan.2013.11.009  0.36
2013 Kwon MJ, Seo J, Kim YJ, Kwon MJ, Choi JY, Kim TE, Lee DH, Park S, Shin YK, Han J, Choi YL. Prognostic significance of CD151 overexpression in non-small cell lung cancer. Lung Cancer (Amsterdam, Netherlands). 81: 109-16. PMID 23570797 DOI: 10.1016/j.lungcan.2013.03.014  0.36
2013 Choi YL, Sun JM, Cho J, Rampal S, Han J, Parasuraman B, Guallar E, Lee G, Lee J, Shim YM. EGFR mutation testing in patients with advanced non-small cell lung cancer: a comprehensive evaluation of real-world practice in an East Asian tertiary hospital. Plos One. 8: e56011. PMID 23468851 DOI: 10.1371/journal.pone.0056011  0.36
2013 Lee HY, Ahn HK, Jeong JY, Kwon MJ, Han JH, Sun JM, Ahn JS, Park K, Choi YL, Ahn MJ. Favorable clinical outcomes of pemetrexed treatment in anaplastic lymphoma kinase positive non-small-cell lung cancer. Lung Cancer (Amsterdam, Netherlands). 79: 40-5. PMID 23103072 DOI: 10.1016/j.lungcan.2012.10.002  0.36
2013 Kang YR, Park HY, Jeon K, Koh WJ, Suh GY, Chung MP, Kim H, Kwon OJ, Choi YL, Han J, Um SW. EGFR and KRAS mutation analyses from specimens obtained by bronchoscopy and EBUS-TBNA Thoracic Cancer. 4: 264-272. DOI: 10.1111/1759-7714.12006  0.36
2012 Yoon HJ, Lee HY, Lee KS, Choi YL, Ahn MJ, Park K, Ahn JS, Sun JM, Kim J, Kim TS, Chung MJ, Yi CA. Repeat biopsy for mutational analysis of non-small cell lung cancers resistant to previous chemotherapy: adequacy and complications. Radiology. 265: 939-48. PMID 22929335 DOI: 10.1148/radiol.12112613  0.36
Show low-probability matches.